News center_innoModel-Provide preclinical pharmacological services

Cn /En

News Center

——

Company news

Industry news

03-06

InnoModels: Features of Host-Versus-Graft-Generation (HVG) Evaluation Platform

With the rapid development of biotechnology and continuous breakthroughs in the field of medicine, the host-versus-graft (HVG) response has become an important indicator of the quality of grafts and the effectiveness of treatment. The host-versus-graft (HVG) evaluation platform launched by InnoModels Biotechnology provides researchers with a one-stop evaluation solution with its unique technological advantages and high degree of accuracy

03-06

InnoModels: Advantages of MHC Humanized Mouse Models

With the deepening of biomedical research, the role of animal models in disease research, drug screening and therapeutic development has become increasingly prominent. Among them, mouse models have become the most commonly used experimental animals because their biological characteristics are highly similar to those of humans. However, traditional mouse models have obvious limitations in the study of certain human-specific diseases, especially those related to the immune system. In this regard, InnoModels Biotechnology has introduced the MHC (Major Histocompatibility Complex) humanized mouse model, which brings a breakthrough in biomedical research

03-05

InnoModels: Characteristics of the PBMC-OncVax tumor vaccine model

In the field of cancer immunotherapy, tumor vaccines are receiving more and more attention as a novel therapeutic strategy. As an experimental model designed for tumor vaccine development, the PBMC-OncVax tumor vaccine model of InnoModels Biotechnology plays an important role in cancer research with its unique features and advantages. In this paper, we will introduce the features of the PBMC-OncVax tumor vaccine model of InnoModels Biotechnology in detail and discuss its application prospects

03-05

InnoModels: Characteristics and Application Prospects of PBMC Mixed Inoculation Models

In biomedical research, human peripheral blood mononuclear cell (PBMC) models are widely used to simulate human immune responses and disease processes. As an advanced experimental tool, the PBMC hybrid inoculation model of InnoModels Biotechnology has attracted wide attention in the field of immunology research with its unique advantages. In this paper, we will introduce the features of the model of hybrid inoculation of InnoModels Biotechnology PBMC and discuss the prospects of its application

< 1...40 41 42...62 >

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License